Minoryx Therapeutics
- Biotech or pharma, therapeutic R&D
Minoryx Therapeutics S.L is a late stage biotech company, focused on the development of new therapies for orphan CNS diseases. The lead program leriglitazone (MIN-102) is now in phase 3/registration for X-ALD
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}